US
Europe

 

US
Europe

 

historymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

 

COLLABORATION PARTNERS

Isotechnika Pharma
Based in Edmonton, Alberta, Canada, Isotechnika Pharma focuses primarily on research and development of immune-modulatory medications, and is currently developing voclosporin for psoriasis and in kidney transplant patients (Isotechnika code ISA247). For further information please visit
www.isotechnika.com

Rutgers, The State University of New Jersey, and the Center for Biomaterials
Established in 1766, Rutgers is America's eighth oldest institution of higher learning and one of the nation's premier public research universities. Serving more than 50,000 students on campuses in Camden, Newark and New Brunswick/Piscataway, Rutgers offers more than 280 bachelors, masters, doctoral and professional degree programs. The university is home to 30 degree-granting schools and colleges, and more than 150 specialized centers and institutes. With 320,000 living alumni, Rutgers graduates are major contributors to all sectors of contemporary life.

The New Jersey Center for Biomaterials, directed by Professor Joachim Kohn, is a research consortium of three universities (Rutgers, New Jersey Institute of Technology, and University of Medicine and Dentistry of New Jersey), about 20 corporate partners including large and small companies with interests in biomaterials science, and a diverse group of research-active faculty.  Established in 1997, the New Jersey Center for Biomaterials has grown into a major, federally funded research center with an extensive biomaterials patent portfolio. So far, six companies have licensed biomaterials technologies developed at the Center. For further information please visit
www.njbiomaterials.org

University of Missouri - Kansas City
Lux Biosciences has established a research collaboration with the University of Missouri - Kansas City and with Professor Ashim Mitra, Chairman, Division of Pharmaceutical Sciences at the University of Missouri - Kansas City. Dr. Mitra is an internationally recognized expert in the field of ocular drug delivery and translational research in ophthalmology. For further information please visit http://pharmacy.umkc.edu/New/pharm/MITRA.html

   
  © 2009 Lux Biosciences, Inc. All rights reserved. Web Terms Deutsch Enlarged Text
   
   

 

LUVENIQ™LX214LX212proprietary technologiespipeline

uveitisdry eye syndromeage-related macular degeneration

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us